Patents by Inventor Paul Gavin

Paul Gavin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL CANNABINOID FORMULATION COMPRISING TOCOPHERYL PHOSPHATES AND LONG CHAIN TRIGLYCERIDES OR LONG CHAIN FATTY ACIDS
    Publication number: 20260183317
    Abstract: The invention relates to an oral cannabinoid formulation comprising: a cannabinoid component comprising a cannabinoid; a carrier in the form of long chain triglyceride (LCT) or long chain fatty acid (LCFA); and a tocopheryl phosphate component comprising mono-(tocopheryl) phosphate (TP) and di-(tocopheryl) phosphate (T2P) wherein the mass ratio of the cannabinoid to the tocopheryl phosphate component is about 10:1 to 1:10.
    Type: Application
    Filed: December 16, 2025
    Publication date: July 2, 2026
    Applicant: AVECHO BIOTECHNOLOGY LIMITED
    Inventor: Paul GAVIN
  • Oral cannabinoid formulation comprising tocopheryl phosphates and long chain triglycerides or long chain fatty acids
    Patent number: 12539307
    Abstract: The invention relates to an oral cannabinoid formulation comprising: a cannabinoid component comprising a cannabinoid; a carrier in the form of long chain triglyceride (LCT) or long chain fatty acid (LCFA); and a tocopheryl phosphate component comprising mono-(tocopheryl) phosphate (TP) and di-(tocopheryl) phosphate (T2P) wherein the mass ratio of the cannabinoid to the tocopheryl phosphate component is about 10:1 to 1:10.
    Type: Grant
    Filed: October 18, 2021
    Date of Patent: February 3, 2026
    Assignee: AVECHO BIOTECHNOLOGY LIMITED
    Inventor: Paul Gavin
  • ORAL CANNABINOID FORMULATION COMPRISING MEDIUM CHAIN TRIGLYCERIDES AND TOCOPHERYL PHOSPHATES
    Publication number: 20230381208
    Abstract: The invention relates to an oral cannabinoid formulation comprising: a cannabinoid component comprising a cannabinoid; a carrier in the form of a medium chain triglyceride (MCT); and a tocopheryl phosphate component comprising mono-(tocopheryl) phosphate (TP) and di-(tocopheryl) phosphate (T2P) wherein the mass ratio of the cannabinoid to the tocopheryl phosphate component is about 10:1 to 1:10.
    Type: Application
    Filed: October 18, 2021
    Publication date: November 30, 2023
    Inventor: Paul GAVIN
  • ORAL CANNABINOID FORMULATION COMPRISING TOCOPHERYL PHOSPHATES AND LONG CHAIN TRIGLYCERIDES OR LONG CHAIN FATTY ACIDS
    Publication number: 20230381207
    Abstract: The invention relates to an oral cannabinoid formulation comprising: a cannabinoid component comprising a cannabinoid; a carrier in the form of long chain triglyceride (LCT) or long chain fatty acid (LCFA); and a tocopheryl phosphate component comprising mono-(tocopheryl) phosphate (TP) and di-(tocopheryl) phosphate (T2P) wherein the mass ratio of the cannabinoid to the tocopheryl phosphate component is about 10:1 to 1:10.
    Type: Application
    Filed: October 18, 2021
    Publication date: November 30, 2023
    Inventor: Paul GAVIN
  • Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
    Patent number: 9168216
    Abstract: The invention relates to a carrier for administering biologically active compounds comprising one or more C1-C4 alcohols, polyols and polymers thereof, water and one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof. The carrier may be used in administering biologically active compounds, in particular pharmaceuticals including cosmetic agents.
    Type: Grant
    Filed: June 16, 2006
    Date of Patent: October 27, 2015
    Assignee: Vital Health Sciences Pty. Ltd.
    Inventors: Paul Gavin, Robert Gianello, Esra Ogru
  • CARRIER COMPRISING ONE OR MORE DI AND/OR MONO-(ELECTRON TRANSFER AGENT) PHOSPHATE DERIVATIVES OR COMPLEXES THEREOF
    Publication number: 20090036354
    Abstract: The invention relates to a carrier for administering biologically active compounds comprising one or more C1-C4 alcohols, polyols and polymers thereof, water and one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof. The carrier may be used in administering biologically active compounds, in particular pharmaceuticals including cosmetic agents.
    Type: Application
    Filed: June 16, 2006
    Publication date: February 5, 2009
    Inventors: Paul Gavin, Robert Gianello, Esra Ogru